Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue

Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue
复制标题

DOI:
10.1007/s00395-013-0349-x
复制
发表时间:
2013-05-01
影响因子:
9.5
通讯作者:
Carrier, Lucie
Carrier, Lucie
中科院分区:
医学1区
文献类型:
--
作者:
Crocini, Claudia;Arimura, Takuro;Carrier, Lucie

文献摘要

被引文献

相似文献

肥厚型心肌病(HCM)是一种与肌节基因突变相关的心肌疾病。在ANKRD1中发现了三个突变,编码锚蛋白重复结构域1(ANKRD1),一种位于肌节中的转录辅因子。在本研究中,我们研究了HCM相关ANKRD1突变的表达是否会影响基因转移后工程心脏组织(EHTs)的收缩参数。EHT由新生大鼠心脏细胞产生,并用编码GFP或myc标记的野生型(WT)或突变体(P52A、T123M或I280V)ANKRD1的腺相关病毒转导。从培养的第8天至第16天分析收缩参数,并在不存在或存在蛋白酶体抑制剂环氧霉素的情况下评价24小时。在标准条件下,只有WT-和T123M-ANKRD1正确地掺入肌节中。T123M-ANKRD1转导的EHT表现出比WT更高的收缩和舒张力和速度。P52A和I280V-ANKRD1是高度不稳定的,不掺入肌节,并且不诱导收缩改变。在环氧霉素处理后,P52A和I280V都被稳定并掺入肌节中。I280V转导的EHTs表现出延长的松弛。这些数据表明AN-KRD1突变对心肌细胞功能的不同影响:T123 M突变在所有条件下的增益功能和I280 V突变的显性负效应,其可能仅在蛋白酶体受损时起作用。
Hypertrophic cardiomyopathy (HCM) is a myocardial disease associated with mutations in sarcomeric genes. Three mutations were found in ANKRD1, encoding ankyrin repeat domain 1 (ANKRD1), a transcriptional co-factor located in the sarcomere. In the present study, we investigated whether expression of HCM-associated ANKRD1 mutations affects contraction parameters after gene transfer in engineered heart tissues (EHTs). EHTs were generated from neonatal rat heart cells and were transduced with adeno-associated virus encoding GFP or myc-tagged wild-type (WT) or mutant (P52A, T123M, or I280V) ANKRD1. Contraction parameters were analyzed from day 8 to day 16 of culture, and evaluated in the absence or presence of the proteasome inhibitor epoxomicin for 24 h. Under standard conditions, only WT- and T123M-ANKRD1 were correctly incorporated in the sarcomere. T123M-ANKRD1-transduced EHTs exhibited higher force and velocities of contraction and relaxation than WT- P52A- and I280V-ANKRD1 were highly unstable, not incorporated into the sarcomere, and did not induce contractile alterations. After epoxomicin treatment, P52A and I280V were both stabilized and incorporated into the sarcomere. I280V-transduced EHTs showed prolonged relaxation. These data suggest different impacts of AN-KRD1 mutations on cardiomyocyte function: gain-offunction for T123M mutation under all conditions and dominant-negative effect for the I280V mutation which may come into play only when the proteasome is impaired.